Turning Point Brands, Inc. (TPB)
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Turning Point Brands, Inc. ("Turning Point” or the "Company") (NYSE: TPB). The investigation concerns whether Turning Point and certain of its officers and/or directors have violated federal securities laws.
On September 17, 2021, Turning Point issued a press release disclosing that it “was informed by the Food and Drug Administration that the agency has issued a Marketing Denial Order (‘MDO’) in response to a Premarket Tobacco Product Application (‘PMTA’) covering certain of the Company’s vapor products.” On this news, Turning Point’s stock price fell $4.37 per share, or 9%, to close at $44.10 per share on September 17, 2021.
If you are aware of any facts relating to this investigation, or purchased Turning Point shares, you can assist this investigation. You can also contact Peretz Bronstein or his Investor Relations Analyst, Yael Nathanson of Bronstein, Gewirtz & Grossman, LLC: 212-697-6484.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation boutique. Our primary expertise is the aggressive pursuit of litigation claims on behalf of our clients. In addition to representing institutions and other investor plaintiffs in class action security litigation, the firm’s expertise includes general corporate and commercial litigation, as well as securities arbitration. Attorney advertising. Prior results do not guarantee similar outcomes.